Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
11
×
national blog main
national top stories
11
×
startups
11
×
life sciences
boston blog main
boston top stories
san francisco blog main
deals
new york blog main
new york top stories
san diego blog main
san diego top stories
cancer
san francisco top stories
boston
raleigh-durham blog main
raleigh-durham top stories
texas blog main
texas top stories
vc
biogen
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
glaxosmithkline
indiana blog main
indiana top stories
investing
ipo
national
novartis
seattle blog main
seattle top stories
venture capital
wisconsin blog main
wisconsin top stories
aducanumab
What
new
11
×
medicines
drug
drugs
bio
biotech
roundup
therapeutics
adds
aims
ceo
developing
disease
earlier
medical
million
research
startup
today
year
activity
address
advance
ago
aiming
alliance
allosteric
ambys
announced
approach
approval
approvals
areas
athena
backed
bails
based
big
biogen
biogen’s
Language
unset
Current search:
new
×
biotech
×
startups
×
" national top stories "
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs